Small caps round-up: Ark Therapeutics, Volex, GoIndustry

Also includes: Blinkx

Medical company Ark Therapeutics said a consortium led by University College London, in which the company was the sole industrial partner engaged in research, was to receive €6m from the EU. The grant would enable Ark's gene-therapy programme in foetal growth restriction to enter into clinical development, it said. Its shares rose 7.4% on the news.

Volex, a provider of electrical, digital and optical connections, said it had appointed David McKinney to the newly created position of Chief Operating Officer (COO). McKinney most recently served as COO of broadcast technology firm Pace from November 2005 to January 2012. The firm said it hoped the new hire would help drive "substantial, sustainable and profitable growth of the company".

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
MoneyWeek

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.